摘要
山莨菪碱与阿托品同属于M胆碱受体拮抗剂。与阿托品相比,山莨菪碱药理作用稍弱,毒副作用也比较低,被广泛用于临床和基础研究。本文主要介绍近年来山莨菪碱药理作用、药动学研究和临床应用方面的进展。
Anisodamine, like atropine, is a muscarinic receptor antagonist. It appears to be less potent and less adverse reactions than atropine. Anisodamine has been widely used in clinical and basic research. This review focuses on the new developments in pharmacological effects, pharmacokinetics and clinical application ofanisodamine.
出处
《世界临床药物》
CAS
2010年第3期182-186,共5页
World Clinical Drug
关键词
山莨菪碱
M受体拮抗剂
药理
临床应用
anisodamine
muscarinic receptor antagonist
pharmacology
clinical application
